Search

everythinglearnresearchcommunity

for

Search:↓

Women with hair loss may have higher heart disease risk.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Alopecia areata may be linked to changes in body fat but not to heart or artery issues.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Early hair loss may indicate higher risk of diabetes and heart disease.

Early hair loss may indicate higher risk of diabetes and heart disease.

Skin changes can signal diabetes and metabolic issues, aiding early diagnosis and treatment.

PCOS involves hormonal imbalance, cysts, and ovulation issues, affecting health and increasing disease risks.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Women with PCOS in Nigeria have higher heart risk markers, needing early heart health checks.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Obesity is common in PCOS patients and early treatment is important for their heart and metabolic health.

People with primary scarring alopecia have higher risks of other health issues like vitamin D deficiency and thyroid disease.

Patients with both connective tissue disease and acid reflux are more likely to have certain symptoms and physical signs.

Older age and existing health conditions increase COVID-19 death risk.

Older age and existing health issues increase COVID-19 death risk.

Patients with mycosis fungoides have a higher risk of heart disease.

PCOS increases the risk of heart disease and type 2 diabetes in women.

Tacrolimus causes fewer acute rejections than cyclosporin A in kidney transplants but doesn't necessarily improve kidney function after one year; cardiovascular risks and side effects vary between the two drugs.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

Skin tags in obese individuals may indicate higher cardiovascular risk.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Hormone therapy is essential for transgender individuals but requires careful management due to possible metabolic effects.

Women with PCOS have a higher risk of diabetes, heart problems, certain cancers, and mental health issues, but early treatment can help manage these risks.